Outcomes in patients with metastatic bladder cancer in the USA: a retrospective electronic medical record study

被引：36
|
作者：
Flannery, Kyle [1 ]
Boyd, Marley [2 ]
Black-Shinn, Jenny [2 ]
Robert, Nicholas [2 ]
Kamat, Ashish M. [3 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ 07033 USA
[2] US Oncol Network McKesson Specialty Hlth, The Woodlands, TX 77380 USA
[3] Univ Texas MD Anderson Canc Ctr, Div Surg, Dept Urol, Houston, TX 77030 USA
来源：
FUTURE ONCOLOGY | 2019年 / 15卷 / 12期
关键词：
bladder cancer; cisplatin eligible; patient outcomes; real-world utilization; treatment patterns; PHASE-II TRIAL; TRANSITIONAL-CELL CARCINOMA; UROTHELIAL CARCINOMA; PACLITAXEL; CISPLATIN; CARBOPLATIN; CHEMOTHERAPY; METHOTREXATE; VINBLASTINE; MULTICENTER;
D O I：
10.2217/fon-2018-0654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Aim: Investigate the effectiveness of chemotherapy for first-line (1L) treatment of metastatic bladder cancer (mBC). Methods: Retrospective cohort study evaluating treatment patterns/outcomes in 1155 mBC patients receiving initial treatment in the community practice setting from January 2010 to June 2014, and followed through July 2016. Results: The most commonly utilized 1L and second-line (2L) regimens were platinum-based and taxane-based, respectively. Median (95% CI) OS for all patients from 1L initiation was 12.8 months (11.7-14.6), and median OS for all 2L regimens was 9.4 months (8.2-11.1). Conclusion: mBC patients eligible for and who received cis-based regimens experienced better OS results. Poor renal function was a key driver of cis-ineligibility. The various monotherapy and combination chemotherapy regimens in 2L produced relatively short OS outcomes.
引用
收藏
页码：1323 / 1334
页数：12
相关论文
共 50 条
  • [31] Bladder-sparing (chemo)radiotherapy in elderly patients with muscle-invasive bladder cancer: a retrospective cohort study
    Verschoor, Noortje
    Heemsbergen, Wilma D.
    Boormans, Joost L.
    Franckena, Martine
    ACTA ONCOLOGICA, 2022, 61 (08) : 1019 - 1025
  • [32] Clinical outcomes following neoadjuvant cisplatin-based chemotherapy for bladder cancer in elderly compared with younger patients
    Chau, C.
    Wheater, M.
    Geldart, T.
    Crabb, S. J.
    EUROPEAN JOURNAL OF CANCER CARE, 2015, 24 (02) : 155 - 162
  • [33] Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims data
    Hess, Lisa M.
    Michael, Diane
    Mytelka, Daniel S.
    Beyrer, Julie
    Liepa, Astra M.
    Nicol, Steven
    GASTRIC CANCER, 2016, 19 (02) : 607 - 615
  • [34] Treatment patterns and outcomes for patients with unresectable stage III and metastatic melanoma in the USA
    Tarhini, Ahmad
    Atzinger, Christopher
    Gupte-Singh, Komal
    Johnson, Courtney
    Macahilig, Cynthia
    Rao, Sumati
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (07) : 461 - 473
  • [35] Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes
    Alhalabi, Omar
    Hahn, Andrew W.
    Msaouel, Pavlos
    Andreev-Drakhlin, Alexander Y.
    Meric-Bernstam, Funda
    Naing, Aung
    Piha-Paul, Sarina
    Filip, Janku
    Pant, Shubham
    Yap, Timothy A.
    Hong, David S.
    Fu, Siqing
    Karp, Daniel
    Campbell, Erick
    Le, Hung
    Campbell, Matthew T.
    Shah, Amishi Y.
    Tannir, Nizar M.
    Siefker-Radtke, Arlene O.
    Gao, Jianjun
    Roszik, Jason
    Subbiah, Vivek
    MOLECULAR CANCER RESEARCH, 2021, 19 (03) : 395 - 402
  • [36] The prognostic effect of metastasis patterns on overall survival in patients with distant metastatic bladder cancer: a SEER population-based analysis
    Shou, Jiafeng
    Zhang, Qi
    Zhang, Dahong
    WORLD JOURNAL OF UROLOGY, 2021, 39 (11) : 4151 - 4158
  • [37] Prognosis of patients receiving induction chemotherapy for locally advanced or lymph node metastatic bladder cancer
    Le Goux, Constance
    Neuzillet, Yann
    Rouanne, Mathieu
    Gachet, Julie
    Staub, Fabrice
    Herve, Jean-Marie
    Yonneau, Laurent
    Abdou, Ali
    Ghoneim, Tarek
    Theodore, Christine
    Lebret, Thierry
    JOURNAL OF CLINICAL UROLOGY, 2020, 13 (06) : 425 - 436
  • [38] Phase II Study of Sunitinib in Patients With Metastatic Urothelial Cancer
    Gallagher, David J.
    Milowsky, Matthew I.
    Gerst, Scott R.
    Ishill, Nicole
    Riches, Jamie
    Regazzi, Ashley
    Boyle, Mary G.
    Trout, Alisa
    Flaherty, Anne-Marie
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (08) : 1373 - 1379
  • [39] Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study
    Dong, Fan
    Shen, Yifan
    Gao, Fengbin
    Xu, Tianyuan
    Wang, Xianjin
    Zhang, Xiaohua
    Zhong, Shan
    Zhang, Minguang
    Chen, Shanwen
    Shen, Zhoujun
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 611 - 626
  • [40] Gemcitabine maintenance versus observation after first-line chemotherapy in patients with metastatic urothelial carcinoma: a retrospective study
    Kim, Hyunho
    Lee, Seung-Hwan
    Kim, Dong Hwan
    Lee, Ji Youl
    Hong, Sung-Hoo
    Ha, U-Syn
    Kim, In-Ho
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (05) : 2113 - 2121
12345